Study

Medisafe Study: Positive Impact on Adherence in HIV Patients Using Single-tablet Antiretroviral Therapy

MIAMI — June 7, 2018  — Medisafe, the leading medication management platform with almost four and a half million registered users, today released data showing that previously non-adherent HIV patients increase their prescription refills after they start using the company’s mobile app. These results are part of a landmark study conducted by IQVIA, a leading global providerRead more.

Study

Medisafe Study: Demonstrating Double-Digit Impact on Medication Adherence in Hypertension Patients

Medisafe, the leading medication management platform with almost four and a half million registered users, released data today showing that, on average, hypertensive patients increase their prescription refills by almost 10% after they start using the company’s mobile app. This novel study is being conducted by the leading global provider of information, innovative technology solutionsRead more.

Study

Medisafe Study: Self-Reported Adherence Data Are Consistent with Prescription Refill Claims

Medisafe, the leading medication management platform with over four million registered users, announced today the first wave of results from a novel study, which among other objectives, measures the accuracy of self-reported outcomes (SROs). Medisafe’s study was conducted in partnership with the leading global provider of information, innovative technology solutions and contract research services focusedRead more.

Adherence

Study: Mobile Phone Apps to Improve Medication Adherence: A Systematic Stepwise Process to Identify High-Quality Apps

Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 02.12.2016 Study Rationale and Background Medication nonadherence leads to an estimated 125,000 deaths and costs $100 billion annually in the US. There is a vast pool of tools, including medication adherence apps, which are now available to help patients manage their regimens. However, many of these appsRead more.